Grants per year
Search results
-
Active
TEAM Registry
Cuttica, M. J. (PD/PI)
International CTEPH Association
10/1/23 → 9/30/26
Project: Research project
-
Prot #INS1009-203: An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension
Cuttica, M. J. (PD/PI)
PPD Development, Insmed Incorporated
4/24/23 → 4/24/26
Project: Research project
-
Prot #CS1-003: A Phase 2, Prospective, Randomized, Open-label, Blinded Endpoint, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of 3 Doses of CS1 in Subjects with Pulmonary Arterial Hypertension
Cuttica, M. J. (PD/PI)
Worldwide Clinical Trials, Inc., Cereno Scientific AB
12/7/22 → 12/7/25
Project: Research project
-
Classification and Prognostication in Pulmonary Thromboembolism Using Computed Tomography Image Analytics
Cuttica, M. J. (PD/PI), Cuttica, M. J. (PD/PI), Mylvaganam, R. J. (Co-Investigator) & Mylvaganam, R. J. (Co-Investigator)
Brigham and Women’s Hospital, National Heart, Lung, and Blood Institute
9/1/22 → 6/30/27
Project: Research project
-
Prot #INS1009-202: A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension
Cuttica, M. J. (PD/PI)
PPD Development, Insmed Incorporated
4/1/22 → 4/1/25
Project: Research project
-
Prot #67896062PAH4005: An International, Non-drug Interventional, Real-world Cohort of PAH Patients Newly Initiating PAH Therapy with Guideline Directed Assessments of Disease Severity: CARE PAH (Contemporary Real-World PAH Best Practice)
Cuttica, M. J. (PD/PI)
Parexel, Actelion Pharmaceuticals Ltd.
1/14/22 → 4/30/27
Project: Research project
-
Prot #67896062CTP3001: Macitentan in Inoperable or Persistent/Recurrent Chronic ThromboEmbolic Pulmonary Hypertension (MACiTEPH): A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel Group, Adaptive Phase 3 Study with Open-l
Cuttica, M. J. (PD/PI)
Janssen Research & Development, LLC
9/21/21 → 9/18/26
Project: Research project
-
Prot #21427/BAY0903201: RiOciguAt UseRs Registry - The ROAR Registry
Cuttica, M. J. (PD/PI)
Xcenda LLC, Bayer HealthCare Pharmaceuticals, Inc.
7/13/21 → 7/31/25
Project: Research project
-
Transitions from Impaired Respiratory Health to Lung Disease
Kalhan, R. (PD/PI), Kalhan, R. (PD/PI), Kalhan, R. (PD/PI), Abdala-Valencia, H. (Co-Investigator), Abdala-Valencia, H. (Co-Investigator), Cuttica, M. J. (Co-Investigator), Cuttica, M. J. (Co-Investigator), Cuttica, M. J. (Co-Investigator), Liu, K. (Co-Investigator), Liu, K. (Co-Investigator), Liu, K. (Co-Investigator), Lloyd-Jones, D. M. (Co-Investigator), Lloyd-Jones, D. M. (Co-Investigator), Lloyd-Jones, D. M. (Co-Investigator), Misharin, A. (Co-Investigator), Misharin, A. (Co-Investigator), Sala, M. A. (Co-Investigator), Sala, M. A. (Co-Investigator) & Sala, M. A. (Co-Investigator)
National Heart, Lung, and Blood Institute
1/1/20 → 6/30/25
Project: Research project
-
Finished
Exploring the Role of T-cell Associated Pulmonary Vasculature Injury and Right Ventricular Dysfunction
Cuttica, M. J. (PD/PI), Budinger, G. S. (Other), Kalhan, R. (Other) & Mylvaganam, R. J. (Other)
Actelion Pharmaceuticals US, Inc.
10/1/21 → 9/30/22
Project: Research project
-
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19
Cuttica, M. J. (PD/PI), Martin, K. A. (PD/PI) & Martin, K. A. (PD/PI)
BloodCenter of Wisconsin, Inc., National Heart, Lung, and Blood Institute
4/19/21 → 6/30/24
Project: Research project
-
Prot #CTEPH.AI: Historical CTPA Cases for Machine Learning/Artificial Intelligence Development
Cuttica, M. J. (PD/PI)
8/12/20 → 8/12/23
Project: Research project
-
Prot #AC-065B302: SELECT: SELExipag in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Group-Sequential, Adaptive, Phase 3 Study with Open-Label
Cuttica, M. J. (PD/PI)
Janssen Research & Development, LLC
8/12/19 → 11/30/24
Project: Research project
-
Prot #AC-055-510: (ORPHEUS) Multicenter, retrospective chart review of first-time Opsumit® (macitentan) users in the United States
Cuttica, M. J. (PD/PI)
PRA Health Sciences, Actelion Pharmaceuticals Ltd.
3/20/18 → 3/20/21
Project: Research project
-
Prot #402-C-1602: An Extended Access Program to Assess Long-Term Safety of Bardoxolone Methy in Patients with Pulmonary Hypertension
Cuttica, M. J. (PD/PI)
PPD Investigator Services, LLC, Reata Pharmaceuticals, Inc.
6/28/17 → 6/30/23
Project: Research project
-
Prot #AC-055-404: A randomized, double-blind, placebo-controlled, prospective, multicenter, parallel group study to assess the safety and efficacy of macitentan in patients with portopulmonary hypertension
Cuttica, M. J. (PD/PI)
PRA Health Sciences, Actelion Pharmaceuticals Ltd.
10/8/15 → 1/31/23
Project: Research project
-
Prot #BPS-314d-MR-PAH-302: A multicenter, double-blind, randomized, placebo-controlled, Phase 3 study to assess the efficacy and safety of oral BPS-314d-MR added-on to treprostinil, inhaled (Tyvaso®) in subjects with pulmonary arterial hypertension
Cuttica, M. J. (PD/PI)
8/12/15 → 2/12/24
Project: Research project
-
Prot #AC-055-503: US-based, observational, drug registry of Opsumit® (macitentan) new users in clinical practice
Cuttica, M. J. (PD/PI)
PRA Health Sciences, Actelion Pharmaceuticals Ltd.
5/28/15 → 5/28/21
Project: Research project
-
Lung Function Decline and Disease Risk from Young Adulthood to Middle Age
Kalhan, R. (PD/PI), Cuttica, M. J. (Co-Investigator), Liu, K. (Co-Investigator), Liu, L. (Co-Investigator) & Shah, S. J. (Co-Investigator)
National Heart, Lung, and Blood Institute
8/1/14 → 12/31/19
Project: Research project
-
Prot# AC-063B201: A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients with Pulmonary Hypertension Secondary to Chroni
Cuttica, M. J. (PD/PI), Dematte D'Amico, J. E. (Co-PD/PI), Kalhan, R. (Co-PD/PI), Rosenberg, S. R. (Co-PD/PI) & Shah, S. J. (Co-PD/PI)
3/19/12 → 3/19/15
Project: Research project
-
Prot#RIN-PH-403: A Postmarketing Observational Study to Assess Respiratory Tract Adverse Events in Pulmonary Arterial Hypertension Patients Treated with Tyvaso (Treprostinil) Inhalation Solution
Cuttica, M. J. (PD/PI), Dematte D'Amico, J. E. (Co-PD/PI) & Shah, S. J. (Co-PD/PI)
United Therapeutics Corporation
9/29/11 → 2/28/15
Project: Research project
-
(TERMINATED 05/01/2012) Prot# BA-I-H-0903: Randomized, Multi-Centre, Controlled Clinical Study on the Effect of the S.A.F.E. bt Therapy on Disease Severity and Inflammation in Mechanically-Ventilated Subjects due to Severe Sepsis
Wunderink, R. G. (PD/PI), Cuttica, M. J. (Co-PD/PI), Dematte D'Amico, J. E. (Co-PD/PI), Ghossein, C. (Co-PD/PI) & Weiss, C. H. (Co-PD/PI)
Theorem Clinical Research, SAFE bt, INC.
6/10/11 → 6/10/14
Project: Research project
-
AGMT 02/10/11: CONFRONT PAH: CombinatiON up-FRON t Therapy for PAH-A Phase 4, Randomized, Multicenter Study of Inhaled Treprostinil in Treatment-naive Pulmonary Arterial Hypertension Patients Starting on Tadalafil
Cuttica, M. J. (PD/PI), Dematte D'Amico, J. E. (Co-PD/PI) & Shah, S. J. (Co-PD/PI)
United Therapeutics Corporation
2/10/11 → 2/10/17
Project: Research project